Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Highly Photoluminescent Nitrogen- and Zinc-Doped Carbon Dots for Efficient Delivery of Crispr/Cas9 and Mrna Publisher Pubmed



Hasanzadeh A1, 2, 3 ; Radmanesh F4, 5 ; Hosseini ES1, 2 ; Hashemzadeh I1, 2, 3 ; Kiani J6, 7 ; Nourizadeh H3 ; Naseri M6, 7 ; Fatahi Y8, 9, 10 ; Chegini F3 ; Madjd Z6, 7 ; Beyzavi A11 ; Kowalski PS12 ; Karimi M1, 2, 3, 6, 13, 14
Authors

Source: Bioconjugate Chemistry Published:2021


Abstract

Safe and efficient delivery of CRISPR/Cas9 systems is still a challenge. Here we report the development of fluorescent nitrogen- and zinc-doped carbon dots (N-Zn-doped CDs) using one-step microwave-aided pyrolysis based on citric acid, branched PEI25k, and different zinc salts. These versatile nanovectors with a quantum yield of around 60% could not only transfect large CRISPR plasmids (∼9 kb) with higher efficiency (80%) compared to PEI25k and lipofectamine 2000 (Lipo 2K), but they also delivered mRNA into HEK 293T cells with the efficiency 20 times greater than and equal to that of PEI25k and Lipo 2K, respectively. Unlike PEI25k, N-Zn-doped CDs exhibited good transfection efficiency even at low plasmid doses and in the presence of 10% fetal bovine serum (FBS). Moreover, these nanovectors demonstrated excellent efficiency in GFP gene disruption by transferring plasmid encoding Cas9 and sgRNA targeting GFP as well as Cas9/sgRNA ribonucleoproteins into HEK 293T-GFP cells. Hence, N-Zn-doped CDs with remarkable photoluminescence properties and high transfection efficiency in the delivery of both CRISPR complexes and mRNA provide a promising platform for developing safe, efficient, and traceable delivery systems for biological research. ©
Other Related Docs
5. Nanoparticles-Mediated Crispr/Cas9 Delivery: Recent Advances in Cancer Treatment, Journal of Drug Delivery Science and Technology (2020)
16. Crispr Pioneers Win 2020 Nobel Prize for Chemistry, Iranian Journal of Public Health (2020)
18. Advancing Mesenchymal Stem Cell Therapy With Crispr/Cas9 for Clinical Trial Studies, Advances in Experimental Medicine and Biology (2020)